Quality Of Life in Patients With Malignant Biliary Obstruction

Memorial Sloan Kettering Cancer Center124 enrolled

Overview

You may have symptoms like itching, abdominal pain, loss of appetite, fatigue, fevers and chills. The treatment you will receive to relieve the blockage is also intended to relieve symptoms and improve your quality of life. The purpose of this study is to find out if relieving the blockage in your bile duct improves your quality of life.

Malignant biliary obstruction (MBO) may arise in patients with cholangiocarcinoma, pancreatic carcinoma, primary gallbladder carcinoma, hepatocellular carcinoma, or metastatic disease to the liver or portal lymph nodes. MBO is often accompanied by significant symptoms that may result in impairment of health-related quality of life (HRQL), including pruritus, fever, nutritional deficits, abdominal pain, nausea and vomiting, and fatigue. Approaches to the relief of MBO include surgical bypass and/or resection, percutaneous drainage with or without biliary stenting, or endoscopic stenting. The non surgical procedures may be done prior to attempted curative resection or for palliation in individuals with unresectable or recurrent disease.

Study Type

OBSERVATIONAL

Enrollment

124

Conditions

Gallbladder Cancer Liver Cancer Bile Duct Cancer

Interventions

questionnairesBEHAVIORAL

complete the FACT-Hep, the SSQ, and the Visual Analog Scale for Pruritus Assessment at 1 week and 4 weeks post procedure.

questionnairesBEHAVIORAL

complete the FACT-Hep, the SSQ, and the Visual Analog Scale for Pruritus Assessment at 1 week and 4 weeks post procedure. Patients who have undergone bypass or resection will complete an additional set of questionnaires at 9 and 14 weeks.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of malignant biliary obstruction * Radiologic or histologic evidence of MBO * Percutaneous biliary drainage procedure planned or * Surgical biliary enteric bypass, or hepatic resection with biliary reconstruction (high bile duct tumors) planned * KPS \>50% * Age 18 years or greater * Able to speak and read English * Able to comprehend and execute informed consent * Prior intervention for MBO not exclusionary Exclusion Criteria: * Unable to complete questionnaire due to performance status * Proxy completion is not accepted * Medical or psychiatric condition that, in the judgment of the investigator, prevents appropriate comprehension and execution of either the informed consent or the study instrument

Locations (1)

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Outcomes

Primary Outcomes

To determine how surgical or percutaneous drainage affects HRQL scores in patients with MBO, and to determine if these changes are sustained or change over time.

Time frame: conclusion of the study

Secondary Outcomes

To identify factors associated with changes in HRQL after drainage(e.g. diagnosis, level of obstruction, degree of pruritus)

Time frame: conclusion of the study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.